USANA Health Sciences lowers Q1 guidance on grim US business
Nutritionals, personal care and weight management products manufacturer USANA Health Sciences, Inc. (Nasdaq:USNA) lowered its first-quarter guidance today due to a year-over-year and consecutive quarter decline in the company’s U.S. business, which accounts for roughly two-thirds of the company’s sales volume. Shares plummeted 33%, or $8.89, to $18.05.
For detailed price information and recent news stories about USANA Health Sciences, click USNA.
